OECI Welcomes New Members to the A&D Board
OECI proudly announces the appointment of three distinguished new members to the Accreditation & Designation Board: Claire Noonan (Beaumont/RCIS Cancer Centre, Dublin), Jorrit Enserik, PhD (Oslo University Hospital Cancer Centre), and Paulina Bravo, MD, PhD (FALP Cancer Centre, Santiago). Each brings a wealth of expertise and a fresh perspective to support the A&D Board’s mission of advancing excellence in cancer care and research across Europe and beyond.
About the A&D Board
The A&D Board plays a critical role in overseeing the OECI Accreditation and Designation Programme, ensuring the highest standards in cancer care and fostering a culture of continuous improvement. The Board’s responsibilities include assessing new applications, approving peer review processes, determining designation types, and monitoring the implementation of improvement plans. This work is integral to OECI’s mission to enhance the quality of cancer care and research through rigorous evaluation and international collaboration.
We warmly welcome Claire, Jorrit, and Paulina to the A&D Board and look forward to their valuable contributions.
Click here to learn more about the OECI A&D Board!
